Lusochimica S.p.A. Recognized with European STEP Seal Award for Eco-Friendly Project
Lusochimica S.p.A., a member of the Menarini Group, has achieved a significant milestone by receiving the prestigious STEP Seal from the European Commission. This accolade highlights the company's innovative efforts in the realm of environmentally friendly pharmaceuticals, particularly through its SmartNEBI project, which focuses on improving the synthesis process of nebivolol, a critical active pharmaceutical ingredient (API) used in cardiovascular treatments.
The STEP Seal symbolizes recognition for projects that demonstrate exceptional potential in clean technologies and sustainable practices. Notably, the SmartNEBI initiative aims to revolutionize nebivolol synthesis by integrating biocatalysis and flow chemistry. This combination allows for safer and more efficient chemical processes, which significantly reduce energy consumption and environmental impact.
Managed by the Health and Digital Executive Agency (HaDEA) under the EU4Health program, the SmartNEBI project addresses cross-border health challenges through innovative solutions. The funding provided not only showcases the European Union's commitment to enhancing public health but also underscores the strategic importance of sustainable technology in the pharmaceutical industry.
Roberto Falorni, the CEO of Lusochimica S.p.A., expressed pride in receiving this distinction, stating that it reinforces the company's dedication to research and innovation in the pharmaceutical sector. He asserted that the SmartNEBI project is a pivotal step towards greener, safer, and more efficient drug production. The initiative aims to streamline solvent usage, optimize energy consumption, and bolster the resilience of the nebivolol supply chain, crucial for the health of millions of patients worldwide.
With its headquarters located in Lomagna, Italy, Lusochimica S.p.A. specializes in the synthesis of pharmaceutical active ingredients and scalable production processes. The company operates three production facilities in Lomagna, Pisa, and Casaletto Lodigiano, all adhering strictly to international cGMP standards.
Globally, the Menarini Group, based in Florence, operates in 140 countries and employs over 17,000 people. The organization is well-known for its commitment to research and development across key therapeutic areas such as cardiology, oncology, and infectious diseases, thus contributing significantly to the global pharmaceutical landscape. Through its 18 manufacturing sites, the group produces over 609 million packages each year, adhering to the highest quality standards to safeguard the health of patients around the world.
The STEP initiative, launched by the EU in early 2024, aims to support European industries by fostering investment in critical technologies, thus nurturing innovation and sustainability across the continent. This funding not only reflects the aspirations for cleaner production but also emphasizes the collaborative efforts of various stakeholders in driving advancements in the pharmaceutical sector. The outcomes and views expressed in relation to the SmartNEBI project embody the collective momentum within the industry to move towards sustainable practices, aligning development goals with environmental stewardship.
In conclusion, the recognition of Lusochimica S.p.A. through the STEP Seal marks a noteworthy achievement in advancing green technologies within the pharmaceutical industry. As the sector grapples with the need for sustainable practices, the SmartNEBI project's innovation may well serve as a benchmark for future developments, driving a collective push towards a healthier planet and enhanced patient care.
The STEP Seal symbolizes recognition for projects that demonstrate exceptional potential in clean technologies and sustainable practices. Notably, the SmartNEBI initiative aims to revolutionize nebivolol synthesis by integrating biocatalysis and flow chemistry. This combination allows for safer and more efficient chemical processes, which significantly reduce energy consumption and environmental impact.
Managed by the Health and Digital Executive Agency (HaDEA) under the EU4Health program, the SmartNEBI project addresses cross-border health challenges through innovative solutions. The funding provided not only showcases the European Union's commitment to enhancing public health but also underscores the strategic importance of sustainable technology in the pharmaceutical industry.
Roberto Falorni, the CEO of Lusochimica S.p.A., expressed pride in receiving this distinction, stating that it reinforces the company's dedication to research and innovation in the pharmaceutical sector. He asserted that the SmartNEBI project is a pivotal step towards greener, safer, and more efficient drug production. The initiative aims to streamline solvent usage, optimize energy consumption, and bolster the resilience of the nebivolol supply chain, crucial for the health of millions of patients worldwide.
With its headquarters located in Lomagna, Italy, Lusochimica S.p.A. specializes in the synthesis of pharmaceutical active ingredients and scalable production processes. The company operates three production facilities in Lomagna, Pisa, and Casaletto Lodigiano, all adhering strictly to international cGMP standards.
Globally, the Menarini Group, based in Florence, operates in 140 countries and employs over 17,000 people. The organization is well-known for its commitment to research and development across key therapeutic areas such as cardiology, oncology, and infectious diseases, thus contributing significantly to the global pharmaceutical landscape. Through its 18 manufacturing sites, the group produces over 609 million packages each year, adhering to the highest quality standards to safeguard the health of patients around the world.
The STEP initiative, launched by the EU in early 2024, aims to support European industries by fostering investment in critical technologies, thus nurturing innovation and sustainability across the continent. This funding not only reflects the aspirations for cleaner production but also emphasizes the collaborative efforts of various stakeholders in driving advancements in the pharmaceutical sector. The outcomes and views expressed in relation to the SmartNEBI project embody the collective momentum within the industry to move towards sustainable practices, aligning development goals with environmental stewardship.
In conclusion, the recognition of Lusochimica S.p.A. through the STEP Seal marks a noteworthy achievement in advancing green technologies within the pharmaceutical industry. As the sector grapples with the need for sustainable practices, the SmartNEBI project's innovation may well serve as a benchmark for future developments, driving a collective push towards a healthier planet and enhanced patient care.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.